MD Anderson Signs Contract For Pyxis ES Technology From CareFusion

      MD Anderson Signs Contract For Pyxis ES Technology From CareFusion

PR Newswire

SAN DIEGO, June 11, 2013

SAN DIEGO, June 11, 2013 /PRNewswire/ -- CareFusion Corp. (NYSE: CFN), a
leading, global medical technology company, today announced a new contract
with The University of Texas MD Anderson Cancer Center for a new Pyxis^® ES
platform for medication dispensing technology.

Terms of the contract include MD Anderson Cancer Center to implement the
Pyxis^® Enterprise Server, Pyxis MedStation^® ES system and the Pyxis^®
Anesthesia ES system for its 600-bed hospital and outpatient centers.

"We are proud to support a national leader like MD Anderson to help ensure the
highest levels of medication safety and medication dispensing efficiency,"
said Rusty Frantz, senior vice president and general manager of Dispensing
Technologies at CareFusion. "For more than 20 years, Pyxis dispensing
technologies have been on the cutting edge of medication and supply management
for hospitals, and the new ES platform is the next leap in that journey."

The new CareFusion Pyxis^® ES platform is a combination of hardware and
software that can significantly reduce time for nursing and pharmacy to
dispense and administer medications because of simpler, more efficient
workflows. The new system also eliminates the need for redundant workflows
through direct synchronization with pharmacy formulary, as well as hospital
and patient identity management systems. The system enables pharmacy and
nursing managers to maintain consistent medication management practices and
policies across multiple hospitals and clinics, which can help improve
medication safety.

About CareFusion Corporation
CareFusion (NYSE: CFN) is a global corporation serving the health care
industry with products and services that help hospitals measurably improve the
safety and quality of care. The company develops industry-leading technologies
including Alaris^® infusion pumps, Pyxis^® automated dispensing and patient
identification systems, AVEA^®, AirLife^® and LTV^® series ventilation and
respiratory products, ChloraPrep^® products, MedMined^® services for data
mining surveillance, V. Mueller^® surgical instruments, and an extensive line
of products that support interventional medicine. CareFusion employs more than
15,000 people across its global operations. More information may be found at

SOURCE CareFusion Corp.

Contact: Media Troy Kirkpatrick, (858) 617-2361,, or Investors Jim Mazzola, (858) 617-1203,
Press spacebar to pause and continue. Press esc to stop.